Navigation Links
Signalife & Athletes Foundation Dispatch Mobile Health Center to Super Bowl
Date:1/30/2008

LOS ANGELES, Jan. 30 /PRNewswire-FirstCall/ -- Athletes for Life Foundation, a 501(c)(3) non-profit foundation duly incorporated in the District of Columbia ("Foundation"), and Signalife (Amex: SGN), have just dispatched to Glendale, Arizona's Super Bowl site the first mobile health center owned by the Foundation. Each mobile health center is named after a professional athlete (across all sports) -- or their families or estates -- who are a part of the cause of eradicating sudden cardiac death and late stage cardiovascular disease. The Ford truck, and 48' attached health center, was sent to Glendale after being dedicated to pro-football great Reggie White -- known as a great and compassionate man, and winner, and one of the all-time great defensive linemen in football history.

Physician groups and health care experts from surrounding states will be stationed at the center to conduct health screenings for all members of the public. The public is invited to attend, and the physicians have indicated they will make every effort to provide screenings to all those in need. When the physicians deem it appropriate, their evaluations will include ambulatory heart screenings utilizing the award-winning Fidelity 100 ambulatory ECG monitor. Signalife believes this to be the only ambulatory ECG monitor capable of detecting subtle shifts and changes in a patient's ECG that are believed to be important to the evaluation of a person's heart health.

The Foundation's Founder, Willie Gault, commented: "I cannot begin to put into words how grateful I am for all of our sponsors who have made these efforts possible. Reggie White was a great man who I knew as a dear friend for many years -- going back to our days together at the University of Tenne
'/>"/>

SOURCE Signalife, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Signalife Provides Corporate Update
2. Legendary Earvin Magic Johnson Joins AFL/Signalife Cardiovascular Protection Team
3. Signalifes Dr. Harmison Launches Award-Winning Ambulatory Heart Monitor
4. Signalife Achieves $1.98 Million Sales Orders Thus Far
5. Signalife Receives Another $3.3 Million Sales Orders
6. NFL Hall of Fame Legend Fred Biletnikoff Joins AFL/Signalife Cardiovascular Protection Team
7. Signalife Continues to Procure Purchase Orders, Revenues
8. Signalife Receives FDA Clearance for OTC Non-Prescription Event Recorder Device
9. U.S. Patent 7,299,083 Awarded to Signalife
10. Signalife Presence at XIII World Congress on Cardiac Pacing and Electrophysiology
11. AMEX Notifies Signalife that It Will Need to Comply with Minimum Stockholders Equity Requirement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...f ultrasmall transistors and more powerful compute...g nanowires are closer to reality after a key disc... the University of California at Los Angeles. , ...es with layers of different materials that are sha...cal requirement for making efficient transistors o...
(Date:11/25/2009)...-- Biotech firm Replikins Ltd., which has analyzed...ic through the prediction, outbreak, and progress ...est biochemical analysis of the virus. The new dat...") virus has dropped from its peak of 3.7 (s.d. 4....ng of 2009 to resting non-epidemic levels this wee...
(Date:11/25/2009)...re/--Formanybusinesses,2009hasbeenapainfulyear.Not...ngnetworkofexpertphysiciansspecializingexclusively...wnthenumberof physiciansinitsnetwork sinceNove...dmorephysician-ownedcenters,includingoneinPuertoRi...gicMDhasopened13newbioidenticalhormonespecialtypra...
(Date:11/25/2009)...wire-Asia/ -- Sinovac Biotech Ltd. ( SVA),a leadi...oday that it executed,a joint venture (JV) agreeme...y Co., Ltd. (Sinovac Dalian). The JV will research...cines. Sinovac will contribute its expertise,and e...class vaccines; the,other party will bring its lan...
Breaking Biology Technology:Nanowires key to future transistors, electronics 2Nanowires key to future transistors, electronics 3Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Biological H1N1 Vaccines: Too Little, Too Late 5Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 2Nation's Largest Network of Doctors Specializing in Bioidentical Hormones Grows at an Exponential Rate 3Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 2Sinovac Establishes Joint Venture to Expand Human-Use Vaccine Development and Manufacturing Capabilities 3
...ent Results in Improvements in Physical ...AN FRANCISCO, Oct. 27 More than half of patients,...of golimumab (CNTO 148),50 mg and 100 mg, an inves...ents in the joint and skin symptoms of active psor...stained through one year.,Golimumab-treated patien...
...apeutics,(Nasdaq: FOLD ) will announce third quar... of markets on Monday, November 3, 2008. The resul...nce call and webcast that,afternoon at 5 p.m. ET.,... the conference call at,5 p.m. ET by dialing 877-4...al). A telephonic replay of the call will be avail...
...FirstCall/ -- China Medical,Technologies, Inc. (th...ed,medical device company that develops, manufactu...ucts today announced that it will report selected,... revenues, net income and,earnings per ADS for the...2Q FY2008") on November 18, 2008 and full unaudite...
Other Biology Technology:One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 2One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 3One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 4One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 5One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 6One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 7One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 8One-Year Data Show Golimumab Improved Signs and Symptoms In Patients with Psoriatic Arthritis In Phase 3 Study 9Amicus Therapeutics Announces Third Quarter 2008 Results Release Date 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 2China Medical Technologies Announces Reporting Dates for the September Quarter Results and Addresses Investor Inquiries 3
(Date:11/25/2009)...he heart pumps some 250 million liters of blood th...e fibers of the heart have to be extremely durable...uer, vice chair of the Department of Medicine III ... Dr. H. A. Katus), has discovered a protein that i...scular unit, the sarcomere. In cooperation with ot...
(Date:11/24/2009)...ors to understanding how sounds associated with Na...al or if they hear it at all. , The same type o...uses to detect flaws in the space shuttle,s behemo...o peek inside the giant head of a whale. The scans... of a whale,s hearing anatomy using a breakthrough...
(Date:11/24/2009)...er 24, 2009) -- The Wildlife Conservation Society ...last remaining population of Siberian tigers has l...e of poaching and habitat loss. , WC...ls of what needs to be done to protect remaining p... The report was released by the Siberian Tige...
Breaking Biology News(10 mins):New genetic cause of cardiac failure discovered 2Rocket science leads to new whale discovery 2Report shows dramatic decline in Siberian tigers 2Palatin Technologies Inc to Report Fourth Quarter and Fiscal Year 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13859 1Palatin Technologies Inc to Report Fourth Quarter and Fiscal Year 2009 Results 3B Teleconference and Webcast to be held on September 8 2009 13859 2Delcath Systems to Present at Rodman 26 Renshaw 11th Annual Healthcare Conference 56246 1Mindray DS USA Appoints Michael Thompson Vice President of U S Ultrasound Sales 56243 1Mindray DS USA Appoints Michael Thompson Vice President of U S Ultrasound Sales 56243 2Mindray DS USA Appoints Michael Thompson Vice President of U S Ultrasound Sales 56243 3
...in sequence data available, scientists are increas... of information that determines a protein,s functi...proteins differ, such information can also help sc...cientists at the U.S. Department of Energy,s Brook...program "to sort the informational ,wheat, from th...
...es plays a role in how our arms and legs develop a... bits of material once dismissed as genetic "junk,...Harvard University. , The research, available toda...ists understand whether bits of RNA called microRN...ment not just by strategically turning off gene ac...
...ationwide will today for the first time be able to...ch for genes that underlie a range of chronic dise...t and other common diseases have been providing bl... of a project hosted by The University of Manchest...re to study genes in chronic diseases. The project...
Other Biology News:Scientists develop protein-sequence analysis tool 2MicroRNA may have fail-safe role in limb development 2'Dating agency' boosts hunt for disease genes 2
... inL10 Workstation from Caliper represents a revol...y, offering for the first time the ability to gene...ly react to changing conditions. In addition, eac... viscosity due to changes in temperature, and offe...
... Series of systems provide fast and reliable scala...s, proteomics and drug development laboratories. S...urations; Mini Workstation Series, Application Ser...cation Series systems use a revolutionary new base...
...over 20 years of experience in providing versatile...the Freedom EVO platform delivers even more flexib... future needs. Together with the new easy-to-use s...to successfully operate genomics, proteomics, and ...
...n Filter is a novel disposable spin filtration dev...f bacterial lysates in plasmid purification proced...disposable spin filtration device especially desig...in plasmid purification procedures. The neutralize...
Biology Products: